Your home for biotech and planetary health insight and opinion.
Let's build rapport.
Writing the future of genetic medicines, with Stylus
Raven-built Stylus is positioned to overcome the existing limitations of genetic medicines with its suite of engineered recombinases that are designed to recognize a safe harbor site in the human genome and introduce a therapeutic payload with high specificity and integrity.
*Keep me informed! I understand I’m opting into letting the RA Capital team contact me, which is totally fine cause they aren’t boring.
about
RApport is an online communications hub for members of the biotech and planetary health communities to share their ideas, problems, and solutions. Founded and run by employees of RA Capital, RApport is a place to gather insight and opinions from across these industries.
We encourage you to share your thoughts with us on Twitter @RApport_Bio.